Skip to main content

HER-2/neu Detection in Fine-Needle Aspirates of Breast Cancer: Fluorescence In Situ Hybridization and Immunocytochemical Analysis

Beatty BG, Bryant R, Wang W, Ashikaga T, Gibson PC, Leiman G, Weaver DL

Publication: Am J Clin Pathol (2004) • Vol 122 • Page 246PMID: 15323142View on PubMed

Purpose

This paper compared the efficacy of immunocytochemical analysis and fluorescence in situ hybridization (FISH) in determining HER-2 status in fine needle aspirates (FNA) and formalin-fixed, paraffin-embedded (FFPE) tissue samples from breast cancer specimens, as well as performed a comparison of fixation methods: formalin, ethanol, and CytoLyt-ThinPrep.

Conclusion

Evaluation of HER-2 expression by immunocytochemistry of cells collected by FNA, regardless of fixative, yielded unreliable results in comparison to FFPE tissue; while results of HER-2 gene expression and FISH analysis of the same cells fixed with ethanol and CytoLyt-ThinPrep strongly correlated with results from FFPE tissue. Authors recommend using FISH to confirm HER-2 status in clinical analyses.

Studies (3)

Purpose

To assess HER-2 protein and gene amplification in formalin fixed paraffin embedded breast cancer tissue.

Summary of Findings

HER-2 protein expression was elevated in 24% of the FFPE specimens analyzed, although only two-thirds of those cases also displayed elevated HER-2 gene expression.
  • Biospecimens

    TissueBreast
  • Preservation Types

    Formalin
  • Diagnoses

    NeoplasticCarcinoma
  • Platforms

    ProteinImmunohistochemistry
    DNAFISH